Erosion blockade breakthrough: Clinical trial signals hope for hand osteoarthritis

Researchers at Ghent University Hospital, Ghent University, and VIB-UGent Center for Inflammation Research, show that antibody therapy can be effective against erosive hand osteoarthritis. Using the antibody denosumab leads to bone remodeling and the prevention of erosive joint damage. This is the first evidence that erosive progression can be halted in this disease. The results appear in Nature Medicine.

This article was originally published on

You may also be interested in:

Read More:

Lawyers Lookup